Guang-yu Lian
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production.
Journal: Cellular and molecular life sciences : CMLS
Published: September 25, 2023
Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis.
Journal: Molecular cancer research : MCR
Published: April 20, 2023
Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects.
Journal: Biomaterials
Published: April 19, 2022
Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin.
Journal: Molecular therapy oncolytics
Published: June 23, 2020
The Mincle/Syk/NF-κB Signaling Circuit Is Essential for Maintaining the Protumoral Activities of Tumor-Associated Macrophages.
Journal: Cancer immunology research
Published: October 09, 2019
Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma.
Journal: Cancer gene therapy
Published: April 24, 2018
Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3/Smad7 Signaling.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 13, 2018
A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro.
Journal: Journal of visualized experiments : JoVE
Published: January 25, 2018
Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells.
Journal: Cancer immunology research
Published: September 05, 2017
Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.
Journal: Nature communications
Published: July 29, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026